Joinn Laboratories(China)Co.,Ltd.

6127.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6127.HK stands at 29.1B. In comparison, 2359.HK has a market cap of 357B. Regarding current trading prices, 6127.HK is priced at HK$21.22, while 2359.HK trades at HK$124.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6127.HK currently has a P/E ratio of 47.16, whereas 2359.HK's P/E ratio is 16.65. In terms of profitability, 6127.HK's ROE is +0.04%, compared to 2359.HK's ROE of +0.28%. Regarding short-term risk, 6127.HK is more volatile compared to 2359.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6127.HK.Check 2359.HK's competition here

6127.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6127.HK stands at 29.1B. In comparison, 2268.HK has a market cap of 76.9B. Regarding current trading prices, 6127.HK is priced at HK$21.22, while 2268.HK trades at HK$61.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6127.HK currently has a P/E ratio of 47.16, whereas 2268.HK's P/E ratio is 45.30. In terms of profitability, 6127.HK's ROE is +0.04%, compared to 2268.HK's ROE of +0.16%. Regarding short-term risk, 6127.HK is more volatile compared to 2268.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6127.HK.Check 2268.HK's competition here

6127.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6127.HK stands at 29.1B. In comparison, 3347.HK has a market cap of 51.8B. Regarding current trading prices, 6127.HK is priced at HK$21.22, while 3347.HK trades at HK$42.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6127.HK currently has a P/E ratio of 47.16, whereas 3347.HK's P/E ratio is 36.19. In terms of profitability, 6127.HK's ROE is +0.04%, compared to 3347.HK's ROE of +0.04%. Regarding short-term risk, 6127.HK is more volatile compared to 3347.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6127.HK.Check 3347.HK's competition here

6127.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6127.HK stands at 29.1B. In comparison, 9860.HK has a market cap of 3B. Regarding current trading prices, 6127.HK is priced at HK$21.22, while 9860.HK trades at HK$4.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6127.HK currently has a P/E ratio of 47.16, whereas 9860.HK's P/E ratio is 140.00. In terms of profitability, 6127.HK's ROE is +0.04%, compared to 9860.HK's ROE of N/A. Regarding short-term risk, 6127.HK is more volatile compared to 9860.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6127.HK.Check 9860.HK's competition here

6127.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6127.HK stands at 29.1B. In comparison, 6667.HK has a market cap of 1.7B. Regarding current trading prices, 6127.HK is priced at HK$21.22, while 6667.HK trades at HK$7.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6127.HK currently has a P/E ratio of 47.16, whereas 6667.HK's P/E ratio is 46.13. In terms of profitability, 6127.HK's ROE is +0.04%, compared to 6667.HK's ROE of +0.05%. Regarding short-term risk, 6127.HK is more volatile compared to 6667.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6127.HK.Check 6667.HK's competition here

6127.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6127.HK stands at 29.1B. In comparison, 8037.HK has a market cap of 673.3M. Regarding current trading prices, 6127.HK is priced at HK$21.22, while 8037.HK trades at HK$0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6127.HK currently has a P/E ratio of 47.16, whereas 8037.HK's P/E ratio is -9.86. In terms of profitability, 6127.HK's ROE is +0.04%, compared to 8037.HK's ROE of -0.55%. Regarding short-term risk, 6127.HK is less volatile compared to 8037.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6127.HK.Check 8037.HK's competition here

6127.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6127.HK stands at 29.1B. In comparison, 2325.HK has a market cap of 485.8M. Regarding current trading prices, 6127.HK is priced at HK$21.22, while 2325.HK trades at HK$0.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6127.HK currently has a P/E ratio of 47.16, whereas 2325.HK's P/E ratio is 83.00. In terms of profitability, 6127.HK's ROE is +0.04%, compared to 2325.HK's ROE of -0.35%. Regarding short-term risk, 6127.HK is more volatile compared to 2325.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6127.HK.Check 2325.HK's competition here

6127.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6127.HK stands at 29.1B. In comparison, 8225.HK has a market cap of 145.3M. Regarding current trading prices, 6127.HK is priced at HK$21.22, while 8225.HK trades at HK$0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6127.HK currently has a P/E ratio of 47.16, whereas 8225.HK's P/E ratio is 7.30. In terms of profitability, 6127.HK's ROE is +0.04%, compared to 8225.HK's ROE of -0.03%. Regarding short-term risk, 6127.HK is more volatile compared to 8225.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6127.HK.Check 8225.HK's competition here

6127.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6127.HK stands at 29.1B. In comparison, 0928.HK has a market cap of 136.9M. Regarding current trading prices, 6127.HK is priced at HK$21.22, while 0928.HK trades at HK$0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6127.HK currently has a P/E ratio of 47.16, whereas 0928.HK's P/E ratio is -3.70. In terms of profitability, 6127.HK's ROE is +0.04%, compared to 0928.HK's ROE of -0.17%. Regarding short-term risk, 6127.HK is less volatile compared to 0928.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6127.HK.Check 0928.HK's competition here